CACLD

AcronymDefinition
CACLDConnecticut Association for Children and Adults with Learning Disabilities
CACLDCalifornia Association of Crime Laboratory Directors
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
We think that in a patient with a newly diagnosed cACLD, a screening with NITs is preferable in order to define the best timing to perform endoscopy or other invasive techniques unless we are facing a decompensated patient.
Weight: 323; IR (KBr max/cm-1): 3059 (Ar-H) 1532 (Ar C=C) 1412 (-SO2-) 1142 (C-N) 562 (C-Cl); 1H- NMR (500 MHz CD3OD ppm): d 7.66 (d J = 9.0 Hz 2H H-2' H-6') 7.46 (d J = 8.5 Hz H-3' H-5')7.05 (d J = 9.0 Hz 2H H-2 H-6) 6.96 (d J = 9.0 Hz 2H H-3 H-5) 3.45 (q J = 7.5 Hz 2H H-1") 2.54 (q J = 7.5 Hz 2H CH2-4) 1.15 (t J= 7.0 Hz3H CH3CH2-4) 0.93 (t J = 7.5 Hz 2H H-2"); HR- MS: [M]+ 323.8335 (Cacld. for C16H18ClNSO2; 324.9586); EIMS (m/z): 325 [M+2]+ (1.5%) 323 [M]+ (6.5%) 259 [M-SO2]+ (3.6%) 175 [C6H4ClSO2]+ (2.1%) 148 [M-C6H4ClSO2]+ (100%) 120 [M-C8H8ClSO2]+ (3.9%) 111 [C6H4Cl]+ (2.7%)105 [M-C8H9ClNSO2]+ (25.3%) 76 [C6H4]+ (6.7%).
124-126 oC; Molecular formula: C20H18ClNSO2; Mol.Weight: 371; IR (KBr max/cm-1): 3057 (Ar-H) 1534 (Ar C=C) 1414 (-SO2-) 1144 (C-N) 564 (C-Cl); 1H- NMR (500 MHz CD3OD ppm): d 7.63 (d J = 9.0 Hz 2H H-2' H-6') 7.48 (d J = 8.5 Hz 2H H-3' H- 5') 7.25-7.22 (m 5H H-2" to H-6") 7.00-7.11 (m4H H-3 to H-6) 4.79 (s 2H H-7") 2.01 (s 3H CH3-2); HR-MS: [M]+ 371.8808 (Cacld. for C20H18ClNSO2; 371.9895); EIMS (m/z): 373 [M+2]+ (8.3%) 371 [M]+ (20.5%) 307 [M-SO2]+ (1.9%) 196 [M-C6H4ClSO2]+ (36%) 175 [C6H4ClSO2]+ (15%) 106 [M-C13H10ClSO2]+ (13%) 111 [C6H4Cl]+ (39%) 91 [M-C13H11ClNSO2]+ (100%) 76 [C6H4]+ (30%) 65 [C5H5] +(41%).
Weight: 371; IR (KBr max/cm-1): 3053 (Ar-H) 1533 (Ar C=C) 1413 (-SO2-) 1143 (C-N) 563 (C-Cl); 1H- NMR (500 MHz CD3OD ppm): d 7.68 (d J = 9.0 Hz 2H H-2' H-6') 7.47 (d J = 8.5 Hz 2H H-3' H- 5') 7.27-7.23 (m 5H H-2" to H-6") 7.09 (d J = 7.5 Hz 1H H-6) 7.05 (s 1H H-2) 6.89-6.83 (m 2H H- 4 H-5) 4.76 (s 2H H-7") 2.21 (s 3H CH3-3); HR- MS: [M]+ 371.8808 (Cacld. for C20H18ClNSO2; 371.9895); EIMS (m/z): 373 [M+2]+ (1%) 371 [M]+ (12%) 307 [M-SO2]+ (1.2%) 196 [M-C6H4ClSO2]+ (21%) 175 [C6H4ClSO2]+ (14%) 111 [C6H4Cl]+ (33%) 106 [M-C13H10ClSO2]+ (32%) 91 [M- C13H11ClNSO2]+ (100%) 76 [C6H4]+ (8.3%) 65 [C5H5] +(39%).
Weight: 371; IR (KBr max/cm-1): 3054 (Ar-H) 1532 (Ar C=C) 1412 (-SO2-) 1142 (C-N) 562 (C-Cl); 1H- NMR (500 MHz CD3OD ppm): d 7.65 (d J = 9.0 Hz 2H H-2' H-6') 7.46 (d J = 8.5 Hz 2H H-3' H- 5') 7.23-7.20 (m 5H H-2" to H-6") 7.02 (d J = 8.5 Hz 2H H-2 H-6) 6.93 (d J = 8.0 Hz 2H H-3 H- 5) 4.77 (s 2H H-7") 2.23 (s 3H CH3-4); HR-MS: [M]+ 371.8808 (Cacld. for C20H18ClNSO2; 371.9895); EIMS (m/z): 373 [M+2]+ (0.7%) 371 [M]+ (10.2%) 307 [M-SO2]+ (1.1%) 196 [M- C6H4ClSO2]+ (19%) 175 [C6H4ClSO2]+ (13%) 111 [C6H4Cl]+ (31%) 106 [M-C13H10ClSO2]+ (29.3%) 91 [M-C13H11ClNSO2]+ (100%) 76 [C6H4]+ (7.7%) 65[C5H5] +(36.4%).
Weight: 385; IR (KBr max/cm-1): 3057 (Ar-H) 1531 (Ar C=C) 1411 (-SO2-) 1141 (C-N) 561 (C- Cl); 1H-NMR (500 MHz CD3OD ppm): d 7.64 (d J = 9.0 Hz 2H H-2' H-6') 7.50 (d J = 8.5 Hz 2H H- 3' H-5') 7.31-7.27 (m 5H H-2" to H-6") 7.18 (dd J = 9.0 3.0 Hz 1H H-6) 7.14 (dt J = 9.5 2.0 Hz 1H H-5) 7.04 (dt J = 9.5 3.0 Hz 1H H-4) 6.95 (dd J = 8.0 3.0 Hz 1H H-3) 4.76 (s 2H H-7") 2.48 (q J = 7.5 Hz 2H CH2-2) 1.01 (t J = 7.5 Hz 3H CH3CH2-2); HR-MS: [M]+ 385.9108 (Cacld. for C21H20ClNSO2; 385.9867); EIMS (m/z): 387 [M+2]+ (8.3%) 385 [M]+ (22.1%) 321 [M-SO2]+ (1.3%) 210 [M-C6H4ClSO2]+ (43.3%) 175 [C6H4ClSO2]+ (6.1%) 120 [M-C13H10ClSO2]+ (1%) 111 [C6H4Cl]+ (35.9%) 105 [M-C13H11ClNSO2]+ (34.1%) 76 [C6H4]+ (9.3%).
Weight: 385; IR (KBr max/cm-1): 3059 (Ar-H) 1532 (Ar C=C) 1412 (-SO2-) 1142 (C-N) 562 (C- Cl); 1H-NMR (500 MHz CD3OD ppm): d 7.66 (d J = 9.0 Hz 2H H-2' H-6') 7.46 (d J = 8.5 Hz H-3' H-5') 7.25-7.22 (m 5H H-2" to H-6") 7.05 (d J = 8.0 Hz 2H H-2 H-6) 6.96 (d J = 8.0 Hz 2H H-3 H-5) 4.75 (s 2H H-7") 2.54 (q J = 7.5 Hz 2H CH2-4) 1.15 (t J= 7.5 Hz 3H CH3CH2-4); HR-MS: [M]+ 385.9123 (Cacld. for C21H20ClNSO2; 385.9867); EIMS (m/z): 387 [M+2]+ (7.9%) 385 [M]+ (21.5%) 321 [M-SO2]+ (1.7%) 210 [M- C6H4ClSO2]+ (41.3%) 175 [C6H4ClSO2]+ (5.7%) 120 [M-C13H10ClSO2]+ (1.6%) 111 [C6H4Cl]+ (31.6%) 105 [M-C13H11ClNSO2]+ (32.6%) 76 [C6H4]+ (9.2%).
Weight: 406; IR (KBr max/cm-1): 3057 (Ar-H) 1534 (Ar C=C) 1414 (-SO2-) 1144 (C-N) 564 (C- Cl); 1H-NMR (500 MHz CD3OD ppm): d 7.63 (d J = 9.0 Hz 2H H-2' H-6') 7.48 (d J = 8.5 Hz 2H H- 3' H-5') 7.34 (d J = 8.5 Hz 2H H-2" H-6") 7.14 (d J = 8.5 Hz 2H H-3" H-5") 7.11-7.00 (m 4H H- 3 to H-6) 4.53 (s 2H H-7") 2.01 (s 3H CH3-2); HR-MS: [M]+ 406.3259 (Cacld. for C20H17Cl2NSO2; 406.3867); EIMS (m/z): 408 [M+2]+ (0.9%) 406 [M]+ (1.5%) 342 [M-SO2]+ (1.1%) 231 [M- C6H4ClSO2]+ (2.9%) 175 [C6H4ClSO2]+ (4.1%) 125 [C7H6Cl]+ (100%) 111 [C6H4Cl]+ (38.7%) 106 [M- C13H9Cl2SO2]+ (20.7%) 91 [M-C13H10Cl2NSO2]+ (57.7%) 76 [C6H4]+ (31.7%).
for [C.sub.16][H.sub.8][C1.sub.3][N.sub.3]; Cacld.: C, 55.12; H, 2.31; N, 12.05; Found: C, 55.00; H, 2.11; N, 11.92 %.
for [C.sub.16][H.sub.9]BrCl[N.sub.3]; Cacld.: C, 53.59; H, 2.53; N, 11.72; Found: C, 53.44; H, 2.40; N, 11.59 %.
for [C.sub.16][H.sub.9]Cl[N.sub.3]; Cacld.: C, 47.38; H, 2.24; N, 10.36; Found: C, 47.18; H, 2.09; N, 10.20 %.
for [C.sub.16][H.sub.9]CI[N.sub.4][O.sub.2]; Cacld.: C, 59.18; H, 2.79; N, 17.25; Found: C, 59.01; H, 2.63; N, 17.06 %.